VOCINTI Trademark

Trademark Overview

On Tuesday, June 21, 2022, a trademark application was filed for VOCINTI with the United States Patent and Trademark Office. The USPTO has given the VOCINTI trademark a serial number of 97468845. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, October 15, 2024. This trademark is owned by Takeda Pharmaceutical Company Limited. The VOCINTI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of gastrointestinal diseases and disorders
vocinti

General Information

Serial Number97468845
Word MarkVOCINTI
Filing DateTuesday, June 21, 2022
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, October 15, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 15, 2024

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of gastrointestinal diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, July 8, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameTakeda Pharmaceutical Company Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressOsaka 540-8645
JP
Party NameTakeda Pharmaceutical Company Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressOsaka 540-8645
JP

Trademark Events

Event DateEvent Description
Friday, June 24, 2022NEW APPLICATION ENTERED
Friday, July 8, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, August 4, 2022ASSIGNED TO EXAMINER
Thursday, August 4, 2022NON-FINAL ACTION WRITTEN
Thursday, August 4, 2022NON-FINAL ACTION E-MAILED
Thursday, August 4, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, November 7, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, January 3, 2023ASSIGNED TO LIE
Wednesday, January 4, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 4, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, February 6, 2023FINAL REFUSAL WRITTEN
Monday, February 6, 2023FINAL REFUSAL E-MAILED
Monday, February 6, 2023NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, February 21, 2023TEAS REQUEST FOR RECONSIDERATION RECEIVED
Tuesday, February 21, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, February 22, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, April 11, 2023ACTION CONTINUING A FINAL - COMPLETED
Tuesday, April 11, 2023CONTINUATION OF FINAL REFUSAL E-MAILED
Tuesday, April 11, 2023NOTIFICATION OF SUBSEQUENT FINAL EMAILED
Thursday, April 20, 2023TEAS REQUEST FOR RECONSIDERATION RECEIVED
Thursday, April 20, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, April 21, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, April 28, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, May 5, 2023ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Wednesday, September 25, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 15, 2024PUBLISHED FOR OPPOSITION
Tuesday, October 15, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Related Keywords

vocinti diseases disorders gastrointestinal treatment preparations pharmaceutical